| AB FCP I-EMERGING MARKETS GROWTH PORTFOLIO A USD | RVI EMERGENTES CRECIMIENTO | 42,14% | 66,57% | 32,83% | 97,44% |
| BGF JAPAN SMALL & MIDCAP OPPORTUNITIES D4 GBP | RVI JAPÓN SMALL/MID CAP | 25,23% | 64,51% | 36,69% | 97,41% |
| BGF WORLD HEALTHSCIENCE E2 EUR | RVI BIOTECNOLOGÍA | 17,23% | 11,97% | 17,30% | 97,41% |
| AB FCP I-EMERGING MARKETS GROWTH PORTFOLIO A HKD | RVI EMERGENTES CRECIMIENTO | 42,10% | 66,53% | 32,80% | 97,40% |
| GOLDMAN SACHS EMERGING MARKETS EQUITY INCOME X CAP USD | RVI EMERGENTES | 42,39% | 79,05% | 43,22% | 97,38% |
| UBS (LUX) EQUITY SICAV - LONG TERM THEMES (USD) (EUR HEDGED) P-ACC | RVI GLOBAL | 13,58% | 29,81% | 19,72% | 97,37% |
| BESTINVER GRANDES COMPAÑIAS, FI | RVI GLOBAL | 6,99% | 22,13% | 13,92% | 97,36% |
| FIDELITY FUNDS-JAPAN EQUITY ESG Y-ACC-JPY | RVI JAPÓN | 20,12% | 33,83% | 23,41% | 97,34% |
| BGF EUROPEAN A4 EUR | RVI EUROPA | 7,86% | 20,39% | 11,61% | 97,31% |
| GOLDMAN SACHS EMERGING MARKETS EQUITY INCOME X CAP EUR | RVI EMERGENTES | 42,73% | 79,20% | 43,40% | 97,31% |
